Find out what makes us such a unique institution and discover the vibrant student life that is at the heart of our community.
Learn more about our key research areas and our research objectives.
See how our research transforms people’s lives in our community, throughout the UK and around the world
We're putting £5.8 million of Office for Students funding towards improving facilities and equipment for our students.
Children who are recovering from severe pneumonia could safely switch from injectable to oral antibiotics earlier, allowing them to come home from hospital sooner.
Dr Sekhon is a mixed methods researcher, with a PhD in Health Psychology and a background in health services research. Her research focuses on the design and evaluation of complex behavioural interventions across a range of long-term conditions.
Dr Sekhon's specific interest is in the advancement of methodology for assessing the acceptability of healthcare interventions and services.
Dr Sekhon completed her PhD in Health Psychology, at City, University of London. The aim of her PhD was to define acceptability in the context of healthcare interventions and to develop a Theoretical Framework of Acceptability that can be applied to assess acceptability qualitatively and quantitatively from two stakeholder perspectives healthcare professionals and patients.
Prior to her current role, Dr Sekhon worked as a Research Fellow for GREAT (Gait Rehabilitation in Early Rheumatoid Arthritis Trial). The GREAT trial was a NIHR HTA funded award, and included a feasibility phase, internal pilot and a RCT. Mandy's responsibilities included, managing the local implementation of trial protocols, leading in the development and assessment of intervention acceptability and fidelity.
Mandy's research interests include applying theory and mixed methods to design, implement and evaluate behaviour change interventions across a range of clinical conditions. Specifically, she is interested in advancing the assessment of acceptability in the context of healthcare interventions and services.
April 2022 – October 2023: Dinah, Crabb, Sekhon, Taylor. Acceptability of intravitreal injections in geographic atrophy (GA): An exploratory study (THE AGAIN Study) Apellis Pharmaceuticals, Inc.
September 2021-August 2022: Sheehan, Guise, Sekhon. Supporting Institutional Responses to Championing the Career Development and Progression of Early Career Researcher(s) UKRI UK Research and Innovation
Browser does not support script.